Contracts › 75N93022C00055
75N93022C00055: "Advanced Development of a Neutralizing Antibody Vaccine for Pandemic and Pre-Emergent Coronaviruses"
Awarded to Duke University by National Institutes of Health (NIH).
$18.0Mobligated
$21.5Mpotential value
31 May 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93022C00055 |
|---|---|
| Awardee | Duke University |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NC |
| Offers received | 10 |
| Period of performance | 19 September 2022 to 31 May 2028 |
| Potential end | 31 May 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record